Prenatal exposure to morphine enhances excitability in locus coeruleus neurons.
Elham AlaeeFatemeh FarahaniSaeed SemnanianHossein AziziPublished in: Journal of neural transmission (Vienna, Austria : 1996) (2022)
Opioid abuse during pregnancy may have noteworthy effects on the child's behavioral, emotional and cognitive progression. In this study, we assessed the effect of prenatal exposure to morphine on electrophysiological features of locus coeruleus (LC) noradrenergic neurons which is involved in modulating cognitive performance. Pregnant dams were randomly divided into two groups, that is a prenatal saline treated and prenatal morphine-treated group. To this end, on gestational days 11-18, either morphine or saline (twice daily, s.c.) was administered to pregnant dams. Whole-cell patch-clamp recordings were conducted on LC neurons of male offspring. The evoked firing rate, instantaneous frequency and action potentials half-width, and also input resistance of LC neurons significantly increased in the prenatal morphine group compared to the saline group. Moreover, action potentials decay slope, after hyperpolarization amplitude, rheobase current, and first spike latency were diminished in LC neurons following prenatal exposure to morphine. In addition, resting membrane potential, rise slope, and amplitude of action potentials were not changed by prenatal morphine exposure. Together, the current findings show a significant enhancement in excitability of the LC neurons following prenatal morphine exposure, which may affect the release of norepinephrine to other brain regions and/or cognitive performances of the offspring.
Keyphrases
- pregnant women
- spinal cord
- simultaneous determination
- mass spectrometry
- high fat diet
- liquid chromatography
- mental health
- physical activity
- body mass index
- spinal cord injury
- transcranial direct current stimulation
- adipose tissue
- risk assessment
- heart rate variability
- insulin resistance
- blood pressure
- high resolution
- climate change
- brain injury
- cell therapy
- subarachnoid hemorrhage